Tag: Cancer Immunotherapy and Biomarkers
-
Combination therapy showed a temporary response in metastatic DDCS
Dual immunotherapy and kinase inhibitor combination shows promise in advanced chondrosarcoma
-
Short-course anti-TB therapy followed regression of reactivated focus
Tuberculosis reactivation during cancer immunotherapy resolved with abbreviated drug therapy
-
FMT with immunotherapy showed activity in NSCLC and melanoma
Gut bacteria transplants enhance immune cancer therapy effectiveness in lung and skin cancers
